CRS: BJMC
Position: Communications Associate
CRS: JHU
Position: Multi-media and Technical Specialist
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
